A pilot study reporting outcomes for melanoma patients of a minimal access ilio-inguinal dissection technique based on two incisions

Annals of Surgical Oncology

Volumn 18, Issue 4, 2011, Pages 970-976

  Spillane, Andrew John ^a,b,c,d,e   Tucker, Monica ^b,f   Pasquali, Sandro ^b,g,h  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

^c Mater Hospital   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f Poche Centre   (Australia)

^g UNIVERSITY OF PADOVA   (Italy)

^h VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEMATOMA; HOSPITALIZATION; HUMAN; ILIO INGUINAL DISSECTION; INCISION; INGUINAL LYMPH NODE; LYMPHEDEMA; MALE; MELANOMA; MORBIDITY; PILOT STUDY; POSTOPERATIVE COMPLICATION; SEROMA; SKIN SURGERY; TREATMENT OUTCOME; WOUND DEHISCENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; INGUINAL CANAL; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHEDEMA; MALE; MELANOMA; MIDDLE AGED; PILOT PROJECTS; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955821308     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1455-8     Document Type: Article

References (39)

1. Coit DG, Andtbacka R, Bichakjian CK, Dilawari RA, Dimaio D, Guild V, et al. Melanoma. J Natl Compr Cancer Netw. 2009;7:250-75.
2. Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand, C.C. Australia, A.C. Network, S.A.N.Z.G. Group. Wellington, 2008.
3. Complete Lymph Node Dissection or Observation in Treating Patients With Localized Melanoma and Sentinel Node Metastasis Who Have Undergone Sentinel Lymphadenectomy. Available from: http://clinicaltrial.gov/ct2/show/NCT00389571? term=MSLT&rank=8, July 6, 2010.
4. MINITUB Study. Available from: http://www.melanomagroup.eu/content/view/ 101/117/, October 9, 2010.
5. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793-6. (Pubitemid 28112341)
6. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-17. (Pubitemid 44465459)
7. Pasquali S, Mocellin S, Campana LG, Bonandini E, Montesco MC, Tregnaghi A, et al. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: personal experience and literature metaanalysis. Cancer. 2010;116:1201-9.
8. Galliot-Repkat C, Cailliod R, Trost O, Sanino A, Collet E, Lambert D, et al. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Eur J Surg Oncol. 2006;32:790-4. (Pubitemid 44276007)
9. Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ratio provides prognostic information in addition to AJCC N stage in patients with melanoma, even if the quality of surgery is standardized. Ann Surg. 2010; [Epub ahead of print].
10. Spillane AJ, Winstanley J, Thompson JF. Lymph node ratio in melanoma: a marker of variation in surgical quality? Cancer. 2009;115:2384-7.
11. Xing Y, Badgwell BD, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115:2505-13.
12. Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15:310-5.
13. Mocellin S, Pasquali S, Rossi CR, Nitti D. Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst. 2010;102: 493-501.
14. Hughes TM, Thomas JM. Combined inguinal and pelvic lymph node dissection for stage III melanoma. Br J Surg. 1999;86: 1493-8.
15. van der Ploeg IM, Kroon BB, Valdes Olmos RA, Nieweg OE. Evaluation of lymphatic drainage patterns to the groin and implications for the extent of groin dissection in melanoma patients. Ann Surg Oncol. 2009;16:2994-9.
16. Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, et al. Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma. Ann Surg Oncol. 2007;14:2867-75. (Pubitemid 47460657)
17. Chang SB, Askew RL, Xing Y, Weaver S, Gershenwald JE, Lee JE, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17: 2764-72.
18. Guggenheim MM, Hug U, Jung FJ, Rousson V, Aust MC, Calcagni M, et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg. 2008;247:687-93. (Pubitemid 351440621)
19. Spillane AJ, Saw RP, Tucker M, Byth K, Thompson JF. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008;248:286-93.
20. Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007;141:728-35. (Pubitemid 46856567)
21. de Vries M, Hoekstra HJ, Hoekstra-Weebers JE. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma. Ann Surg Oncol. 2009;16:2840-7.
22. de Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ. Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol. 2006;32:785-9. (Pubitemid 44276020)
23. Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozillo N. The Impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17:3324-9.
24. Moseley A, Piller N, Carati C. Combined opto-electronic perometry and bioimpedance to measure objectively the effectiveness of a new treatment intervention for chronic secondary leg lymphedema. Lymphology. 2002;35:136-43. (Pubitemid 36169318)
25. Jacobs LK, Balch C, Coit DG. Inguinofemoral, iliac/obturator, and popliteal lymphadenectomy in patients with melanoma. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma, St. Louis, MO: Quality Medical Publishing; 2009.
26. Spratt J. Groin dissection. J Surg Oncol. 2000;73:243-62. (Pubitemid 30238421)
27. Lanitis S, Tekkis PP, Sgourakis G, Dimopoulos N, Al Mufti R, Hadjiminas DJ. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg. 251:632-9.
28. Spratt JS. An update on incision for ilioinguinal lymph node dissection. Am J Surg. 1992;164:163-5; discussion 166.
29. Rapaport D, Stadelmann WK, Reintgen D. Inguinal lymphadenectomy. In Balch CM, Houghton AN, Sober AJ, Soong SJ, Atkins MB, Thompson JF, editors. Cutaneous melanoma. St. Louis, MO: Quality Medical Publishing; 2009. p. 269-80.
30. Spillane AJ, Cheung BL, Stretch JR, Scolyer RA, Shannon KF, Quinn MJ, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249:473-80.
31. Ali-Khan AS, Crundwell M, Stone C. Inguinal lymphadenectomy combined with staging endoscopic pelvic node sampling for stage III melanoma. J Plast Reconstr Aesthet Surg. 2009;62:1063-7.
32. Jones WO, Cable RL, Gilling PJ. Laparoscopic pelvic lymphadenectomy for malignant melanoma. Aust N Z J Surg. 1995;65:765-7.
33. Picciotto F, Volpi E, Zaccagna A, Siatis D. Transperitoneal laparoscopical iliac lymphadenectomy for treatment of malignant melanoma. Surg Endosc. 2003;17:1536-40. (Pubitemid 37467614)
34. Schneider C, Brodersen JP, Scheuerlein H, Tamme C, Lippert H, Kockerling F. Combined endoscopic and open inguinal dissection for malignant melanoma. Langenbecks Arch Surg. 2003;388: 42-7. (Pubitemid 37092464)
35. Trias M, Targarona EM, Piulachs J, Balagué C, Bombuy E, Espert JJ, et al. Extraperitoneal laparoscopically assisted ilioinguinal lymphadenectomy for treatment of malignant melanoma. Arch Surg. 1998;133:272-4; discussion 275.
36. Delman KA, Kooby DA, Ogan K, Hsiao W, Master V. Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010; 17:731-7.
37. Delman KA, Kooby DA, Rizzo K, Organ K, Maithel SK, Master V. Growing experience with videoscopic inguinal lymphadenectomy (VIL): moving to better outcomes. Ann Surg Oncol. 2010;17:S15.
38. Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg. 2000;87:892-901. (Pubitemid 30487692)
39. Sommariva A, Pasquali S, Rossi CR. Lymphadenectomy for melanoma: towards a videoscopic approach. Ann Surg Oncol. 2010 [Epub ahead of print].